Anna Bornefalk‐Hermansson

1.3k total citations
20 papers, 855 citations indexed

About

Anna Bornefalk‐Hermansson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna Bornefalk‐Hermansson has authored 20 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna Bornefalk‐Hermansson's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Respiratory Support and Mechanisms (6 papers) and Respiratory and Cough-Related Research (3 papers). Anna Bornefalk‐Hermansson is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Respiratory Support and Mechanisms (6 papers) and Respiratory and Cough-Related Research (3 papers). Anna Bornefalk‐Hermansson collaborates with scholars based in Sweden, Australia and United States. Anna Bornefalk‐Hermansson's co-authors include Magnus Ekström, David C. Currow, Amy P. Abernethy, Kerstin Ström, Zainab Ahmadi, Josefin Sundh, Hans Bornefalk, Erik Lampa, Lars Lind and Peter Lind and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Anna Bornefalk‐Hermansson

20 papers receiving 836 citations

Peers

Countries citing papers authored by Anna Bornefalk‐Hermansson

Since Specialization

Citations

This map shows the geographic impact of Anna Bornefalk‐Hermansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bornefalk‐Hermansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bornefalk‐Hermansson more than expected).

Fields of papers citing papers by Anna Bornefalk‐Hermansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bornefalk‐Hermansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bornefalk‐Hermansson. The network helps show where Anna Bornefalk‐Hermansson may publish in the future.

Co-authorship network of co-authors of Anna Bornefalk‐Hermansson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bornefalk‐Hermansson. A scholar is included among the top collaborators of Anna Bornefalk‐Hermansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bornefalk‐Hermansson. Anna Bornefalk‐Hermansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease 2021 ·ERJ Open Research ·Zainab Ahmadi, Helena Igelström, Jacob Sandberg, Josefin Sundh, Magnus Sköld, Christer Janson, Anders Blomberg, (unknown), Anna Bornefalk‐Hermansson, Magnus Ekström	12
2	Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease 2020 ·Journal of Pain and Symptom Management ·Magnus Ekström, (unknown), C. Magnus Sköld, Christer Janson, Anders Blomberg, Anna Bornefalk‐Hermansson, Helena Igelström, Jacob Sandberg, Josefin Sundh	33
3	Respiratory outcomes after a 1-year treatment of obstructive sleep apnoea with bibloc versus monobloc oral appliances: a multicentre, randomized equivalence trial 2020 ·Acta Odontologica Scandinavica ·Åke Tegelberg, Eva Nohlert, Anna Bornefalk‐Hermansson, Anette M.C. Fransson, Göran Isacsson	12
4	REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol 2019 ·BMC Pulmonary Medicine ·Josefin Sundh, Anna Bornefalk‐Hermansson, Zainab Ahmadi, Anders Blomberg, Christer Janson, David C. Currow, Christine F. McDonald, Nikki McCaffrey, Magnus Ekström	13
5	Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease 2019 ·BMJ Open Respiratory Research ·Magnus Ekström, (unknown), Magnus Sköld, Christer Janson, Anders Blomberg, Jacob Sandberg, Anna Bornefalk‐Hermansson, Helena Igelström, Josefin Sundh	25
6	Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease 2019 ·BMJ Open Respiratory Research ·Josefin Sundh, (unknown), C. Magnus Sköld, Christer Janson, Anders Blomberg, Jacob Sandberg, Anna Bornefalk‐Hermansson, Helena Igelström, Magnus Ekström	20
7	Spirometric Volumes and Breathlessness across Levels of Airflow Limitation: The COPDGene Study 2018 ·American Journal of Respiratory and Critical Care Medicine ·Magnus Ekström, Anna Bornefalk‐Hermansson, Nicholas G. Wysham, David C. Currow, Neil R. MacIntyre	5
8	Use of bibloc and monobloc oral appliances in obstructive sleep apnoea: a multicentre, randomized, blinded, parallel-group equivalence trial 2018 ·European Journal of Orthodontics ·Göran Isacsson, Eva Nohlert, Anette M.C. Fransson, Anna Bornefalk‐Hermansson, Eva Eriksson, (unknown), (unknown), (unknown), (unknown), (unknown), Thomas List, (unknown), Åke Tegelberg	18
9	Surgery for Chronic Otitis Media Causes Greater Taste Disturbance Than Surgery for Otosclerosis 2018 ·Otology & Neurotology ·(unknown), Anna Bornefalk‐Hermansson, Johan Knutsson, Magnus von Unge	7
10	Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease 2016 ·PLoS ONE ·Zainab Ahmadi, Josefin Sundh, Anna Bornefalk‐Hermansson, Magnus Ekström	29
11	Cardiovascular and antacid treatment and mortality in oxygen‐dependent pulmonary fibrosis: A population‐based longitudinal study 2016 ·Respirology ·Magnus Ekström, Anna Bornefalk‐Hermansson	19
12	Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy 2016 ·Cochrane Database of Systematic Reviews ·Magnus Ekström, Zainab Ahmadi, Anna Bornefalk‐Hermansson, Amy P. Abernethy, David C. Currow	61
13	The identification of complex interactions in epidemiology and toxicology: a simulation study of boosted regression trees 2014 ·Environmental Health ·Erik Lampa, Lars Lind, Peter Lind, Anna Bornefalk‐Hermansson	45
14	Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study 2014 ·BMJ ·Magnus Ekström, Anna Bornefalk‐Hermansson, Amy P. Abernethy, David C. Currow	191
15	Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study 2014 ·Respiratory Research ·Zainab Ahmadi, Anna Bornefalk‐Hermansson, Karl A. Franklin, Bengt Midgren, Magnus Ekström	47
16	Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease 2013 ·American Journal of Respiratory and Critical Care Medicine ·Magnus Ekström, Anna Bornefalk‐Hermansson, Kerstin Ström	112
17	Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada? 2013 ·European Heart Journal Acute Cardiovascular Care ·Nina Johnston, Anna Bornefalk‐Hermansson, Karin Schenck‐Gustafsson, Claes Held, Shaun G. Goodman, Andrew T. Yan, Arlene S. Bierman	33
18	An investigation of the co-variation in circulating levels of a large number of environmental contaminants 2012 ·Journal of Exposure Science & Environmental Epidemiology ·Erik Lampa, Lars Lind, Anna Bornefalk‐Hermansson, Samira Salihović, Bert van Bavel, Peter Lind	23
19	Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial 2012 ·The Lancet ·Torsten Sandberg, Gunilla Skoog, Anna Bornefalk‐Hermansson, Gunnar Kahlmeter, (unknown), Anders Lannergård, Gisela Otto, Bo Settergren, (unknown)	119
20	On the comparison of FROC curves in mammography CAD systems 2005 ·Medical Physics ·Hans Bornefalk, Anna Bornefalk‐Hermansson	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact